China Biologic secures $1.1bn loan for privatisation

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings
Asia

China Biologic secures $1.1bn loan for privatisation

Pan Yue
November 23, 2020 05:45 AM
pills adobe stock 575x375 pharmaceuticals

Two Chinese banks have agreed to arrange a $1.1bn loan to support China Biologic Products Holdings’ delisting from the Nasdaq stock exchange.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Syndicated LoansHealth and BiotechChinaAsiaGreater ChinaNortheast AsiaShanghai Pudong Development BankLoans and High YieldAsia PacificLevFinLeveraged LoansEmerging Market LoansLevFin Leveraged LoansEmerging MarketsSRI
PY
Pan Yue
Loans reporter GlobalCapital Asia
Contact
Gift this article